- Home
- XOMA vs DSM Comparison
XOMA vs DSM Comparison
Compare XOMA & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMA
- DSM
- Stock Information
- Founded
- XOMA 1981
- DSM 1989
- Country
- XOMA United States
- DSM United States
- Employees
- XOMA N/A
- DSM N/A
- Industry
- XOMA Biotechnology: Pharmaceutical Preparations
- DSM Investment Managers
- Sector
- XOMA Health Care
- DSM Finance
- Exchange
- XOMA Nasdaq
- DSM Nasdaq
- Market Cap
- XOMA 330.2M
- DSM 280.8M
- IPO Year
- XOMA N/A
- DSM N/A
- Fundamental
- Price
- XOMA $30.85
- DSM $5.60
- Analyst Decision
- XOMA Strong Buy
- DSM
- Analyst Count
- XOMA 2
- DSM 0
- Target Price
- XOMA $69.50
- DSM N/A
- AVG Volume (30 Days)
- XOMA 30.3K
- DSM 161.7K
- Earning Date
- XOMA 08-13-2025
- DSM 01-01-0001
- Dividend Yield
- XOMA N/A
- DSM 3.97%
- EPS Growth
- XOMA N/A
- DSM N/A
- EPS
- XOMA N/A
- DSM N/A
- Revenue
- XOMA $44,952,000.00
- DSM N/A
- Revenue This Year
- XOMA $70.91
- DSM N/A
- Revenue Next Year
- XOMA $14.00
- DSM N/A
- P/E Ratio
- XOMA N/A
- DSM N/A
- Revenue Growth
- XOMA 194.98
- DSM N/A
- 52 Week Low
- XOMA $18.35
- DSM $4.69
- 52 Week High
- XOMA $35.00
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- XOMA 67.84
- DSM 56.58
- Support Level
- XOMA $25.15
- DSM $5.60
- Resistance Level
- XOMA $33.15
- DSM $5.70
- Average True Range (ATR)
- XOMA 1.69
- DSM 0.06
- MACD
- XOMA 0.59
- DSM 0.01
- Stochastic Oscillator
- XOMA 79.66
- DSM 70.83
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.